Strive Pharmacy pricing vs pass-through: which model fits a clinic?

Strive's clinic agreement can win when you only ever order Strive SKUs, value their Find a Provider directory for patient acquisition, and are comfortable confirming per-vial cost after onboarding rather than before the consult. The upside is a single trusted compounder relationship with deep formulary breadth from hormones to skincare. The risk is that the rate is unverifiable up front and may pair with shipping, day-supply, and handling charges that change landed cost.

Pass-through pricing wins when a cash-pay or telehealth clinic needs to quote patients on landed cost before the consult, batches dozens of GLP-1, hormone, or peptide refills across compounders in one session, and wants validation before payment. Its limit is that Fizy Health is the ordering ops layer — not the compounder — so you need Strive (or another 503A partner) in your assigned network for the SKUs you order. Most GLP-1-heavy clinics care most about knowing per-vial cost before they set patient pricing, which tends to favor pass-through visibility.

Do not decide on model labels; decide on landed cost for your real SKUs. Get an itemized Strive clinic agreement from pricing@strivepharmacy.com that separates drug cost from shipping and handling on your top three SKUs, then open a pass-through catalog and read the visible per-vial cost plus disclosed facilitation fee on the same drug, strength, and vial size. Normalize both to delivered per-vial cost over a representative month.

With Fizy Health you can do half of that comparison immediately, because it shows resolved per-vial 503A cost on each catalog and cart line before checkout and discloses a single facilitation fee at payment. Build a representative cart, read the totals, and set that against your Strive agreement. Whichever model delivers lower true landed cost on the SKUs you actually order is the right choice — and now you can prove it rather than assume it.